HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Net Cash Flow (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Net Cash Flow came in at $382.8 million in Q2 2021, up 1601.11% year-over-year from $22.5 million in Q2 2020, and up 245.1% quarter-over-quarter from $110.9 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Net Cash Flow (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Net Cash Flow for 4 consecutive years, with $382.8 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Net Cash Flow rose 1601.11% year-over-year to $382.8 million in Q2 2021; TTM through Jun 2021 was $479.4 million, a 279.31% increase from a year earlier, with the FY2025 full-year figure at -$86.2 million, up 31.69% from the prior year.
  • Net Cash Flow was $382.8 million for Q2 2021 at HUTCHMED (China), up from $110.9 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $382.8 million in Q2 2021 and troughed at -$26.8 million in Q2 2018.
  • A 4-year average of $63.6 million and a median of $48.4 million in 2018 frame the typical range for Net Cash Flow.
  • Across the five-year window, Net Cash Flow plunged 494.75% in 2020 and jumped 1601.11% in 2021, its largest moves.
  • Over 4 years, Net Cash Flow stood at $14.7 million in 2018, then surged by 297.29% to $58.5 million in 2019, then sank by 143.59% to -$25.5 million in 2020, then jumped by 1601.11% to $382.8 million in 2021.
  • The last three Net Cash Flow figures came in at $382.8 million (Q2 2021), $110.9 million (Q1 2021), and -$25.5 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 212.49 Bn 198.50 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 180.93 Bn 177.75 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 132.39 Bn 124.53 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 82.17 Bn 74.18 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 61.05 Bn 55.87 Bn 1.37 Bn -
6 Moderna 55.19 Bn 50.05 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 33.99 Bn 30.68 Bn 992.69 Mn -496,000.00
8 Biogen 31.30 Bn 30.01 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 29.91 Bn 29.91 Bn 1.16 Mn -170.75 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 382.83 Mn
Mar 31, 2021 110.93 Mn
Jun 30, 2020 -25.50 Mn
Mar 31, 2020 11.10 Mn
Dec 31, 2019 58.51 Mn
Sep 30, 2019 82.27 Mn
Jun 30, 2019 -4.29 Mn
Mar 31, 2019 61.96 Mn
Dec 31, 2018 14.73 Mn
Sep 30, 2018 43.56 Mn
Jun 30, 2018 -26.78 Mn
Mar 31, 2018 53.32 Mn